Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian CancerSanghoon Lee, Anil K. Sood, Joseph Celestino et al.|Cell Reports|2020Cited by 144
Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian CancerShannon N. Westin, Gordon B. Mills, Marilyne Labrie et al.|Clinical Cancer Research|2021Cited by 76
Phase 1b dose expansion and translational analyses of olaparib in combination with the oral AKT inhibitor capivasertib in recurrent endometrial, triple negative breast, and ovarian, primary peritoneal, or fallopian tube cancerShannon N. Westin, Gordon B. Mills, Marilyne Labrie et al.|medRxiv|2021Cited by 11